Denali Therapeutics Inc (DNLI)
24.26
-0.16
(-0.68%)
USD |
NASDAQ |
Nov 21, 16:00
24.26
0.00 (0.00%)
After-Hours: 19:38
Denali Therapeutics Price to Book Value: 2.648 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.666 |
| November 19, 2024 | 2.657 |
| November 18, 2024 | 2.639 |
| November 15, 2024 | 2.734 |
| November 14, 2024 | 3.106 |
| November 13, 2024 | 3.234 |
| November 12, 2024 | 3.263 |
| November 11, 2024 | 3.447 |
| November 08, 2024 | 3.422 |
| November 07, 2024 | 3.231 |
| November 06, 2024 | 3.226 |
| November 05, 2024 | 3.018 |
| November 04, 2024 | 2.970 |
| November 01, 2024 | 2.953 |
| October 31, 2024 | 2.834 |
| October 30, 2024 | 2.931 |
| October 29, 2024 | 2.997 |
| October 28, 2024 | 3.031 |
| October 25, 2024 | 2.853 |
| October 24, 2024 | 2.884 |
| October 23, 2024 | 2.845 |
| October 22, 2024 | 2.868 |
| October 21, 2024 | 2.878 |
| October 18, 2024 | 3.010 |
| October 17, 2024 | 2.991 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.018 |
| October 15, 2024 | 2.929 |
| October 14, 2024 | 2.927 |
| October 11, 2024 | 3.055 |
| October 10, 2024 | 2.808 |
| October 09, 2024 | 2.893 |
| October 08, 2024 | 2.916 |
| October 07, 2024 | 2.902 |
| October 04, 2024 | 3.123 |
| October 03, 2024 | 3.079 |
| October 02, 2024 | 3.167 |
| October 01, 2024 | 3.128 |
| September 30, 2024 | 3.178 |
| September 27, 2024 | 3.038 |
| September 26, 2024 | 3.021 |
| September 25, 2024 | 2.993 |
| September 24, 2024 | 3.130 |
| September 23, 2024 | 3.121 |
| September 20, 2024 | 3.190 |
| September 19, 2024 | 3.205 |
| September 18, 2024 | 3.175 |
| September 17, 2024 | 3.167 |
| September 16, 2024 | 3.130 |
| September 13, 2024 | 3.176 |
| September 12, 2024 | 2.886 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.465
Minimum
Apr 25 2024
12.71
Maximum
Dec 22 2020
4.560
Average
4.342
Median
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 4.627 |
| Perspective Therapeutics Inc | 0.6153 |
| Protalix BioTherapeutics Inc | 3.791 |
| Electromed Inc | 5.682 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 11.14 |
| Price | 24.26 |
| Earnings Yield | -11.38% |
| Market Cap | 3.491B |